However, no polymorphisms have been reported for SLPI or elafin, and therefore, the question remains open as to whether a deficit in either SLPI or elafin contributes to the development of COPD in patients who otherwise have sufficient levels of AAT and ACT. The gene discussed is SLPI; the disease is chronic obstructive pulmonary disease.